FR2179044A1 - - Google Patents

Info

Publication number
FR2179044A1
FR2179044A1 FR7311945A FR7311945A FR2179044A1 FR 2179044 A1 FR2179044 A1 FR 2179044A1 FR 7311945 A FR7311945 A FR 7311945A FR 7311945 A FR7311945 A FR 7311945A FR 2179044 A1 FR2179044 A1 FR 2179044A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7311945A
Other languages
French (fr)
Other versions
FR2179044B1 (US20090163788A1-20090625-C00002.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of FR2179044A1 publication Critical patent/FR2179044A1/fr
Application granted granted Critical
Publication of FR2179044B1 publication Critical patent/FR2179044B1/fr
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/025Applications of microcapsules not provided for in other subclasses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7311945A 1972-04-03 1973-04-03 Expired FR2179044B1 (US20090163788A1-20090625-C00002.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24083472A 1972-04-03 1972-04-03

Publications (2)

Publication Number Publication Date
FR2179044A1 true FR2179044A1 (US20090163788A1-20090625-C00002.png) 1973-11-16
FR2179044B1 FR2179044B1 (US20090163788A1-20090625-C00002.png) 1980-05-23

Family

ID=22908131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7311945A Expired FR2179044B1 (US20090163788A1-20090625-C00002.png) 1972-04-03 1973-04-03

Country Status (5)

Country Link
JP (1) JPS5116926B2 (US20090163788A1-20090625-C00002.png)
CA (1) CA1041905A (US20090163788A1-20090625-C00002.png)
DE (1) DE2316242A1 (US20090163788A1-20090625-C00002.png)
FR (1) FR2179044B1 (US20090163788A1-20090625-C00002.png)
GB (1) GB1388786A (US20090163788A1-20090625-C00002.png)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358895A1 (fr) * 1976-05-05 1978-02-17 Lowey Hans Excipient pour compositions therapeutiques en comprimes
FR2366835A1 (fr) * 1976-10-06 1978-05-05 Wyeth John & Brother Ltd Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant
FR2372600A1 (fr) * 1976-12-01 1978-06-30 Merck & Co Inc Composition epaississante pour assaisonnement pour la salade, maniable a la cuiller et exempt d'amidon
EP0078215A2 (fr) * 1981-10-26 1983-05-04 Rhone-Poulenc Sante Nouvelle forme galénique solide pour administration par voie orale et son procédé de préparation
EP0227050A1 (de) * 1985-12-19 1987-07-01 Capsoid Pharma GmbH Verfahren zur Herstellung von einzeln dosierten Darreichungsformen sowie die danach erhältlichen Darreichungsformen
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
WO1995023591A1 (en) * 1994-03-03 1995-09-08 The Procter & Gamble Company Oral vehicle compositions
FR2725624A1 (fr) * 1994-10-14 1996-04-19 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
WO1998010752A2 (de) * 1996-09-13 1998-03-19 Basf Aktiengesellschaft Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
WO1998026865A1 (en) * 1996-12-17 1998-06-25 Chemcolloids Limited Encapsulation
WO1999024020A1 (en) * 1997-11-12 1999-05-20 The Dow Chemical Company A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
WO1999034780A1 (de) * 1998-01-12 1999-07-15 Bühler AG Verfahren und vorrichtung zum verkapseln von wirkstoffen
EP0596203B1 (de) * 1992-08-13 1999-11-17 BASF Aktiengesellschaft Wirkstoffe und wasserlösliche Polymeren enthaltende Zubereitungen in Form fester Teilchen

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
DE4446380A1 (de) * 1994-07-05 1996-01-11 Lohmann Therapie Syst Lts Hydrogel für die Applikation von therapeutischen und/oder kosmetischen Wirkstoffen an die Haut
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
KR20000069356A (ko) * 1997-10-07 2000-11-25 리차드 디. 슈미트 급속방출식 약물전달 제형
WO2006125857A1 (en) * 2005-05-26 2006-11-30 Mika Tapio Reijonen Composition and manufacturing process of cetraria islandica based polymer blend
ITMI20080636A1 (it) * 2008-04-10 2009-10-11 Biophil S R L Patch per uso dermico

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358895A1 (fr) * 1976-05-05 1978-02-17 Lowey Hans Excipient pour compositions therapeutiques en comprimes
FR2366835A1 (fr) * 1976-10-06 1978-05-05 Wyeth John & Brother Ltd Element de forme destine a renfermer une substance chimique, son procede de preparation et emballage le contenant
FR2372600A1 (fr) * 1976-12-01 1978-06-30 Merck & Co Inc Composition epaississante pour assaisonnement pour la salade, maniable a la cuiller et exempt d'amidon
EP0078215A2 (fr) * 1981-10-26 1983-05-04 Rhone-Poulenc Sante Nouvelle forme galénique solide pour administration par voie orale et son procédé de préparation
EP0078215A3 (en) * 1981-10-26 1984-03-28 Rhone-Poulenc Sante Solid galenic form for oral administration and process for its preparation
EP0227050A1 (de) * 1985-12-19 1987-07-01 Capsoid Pharma GmbH Verfahren zur Herstellung von einzeln dosierten Darreichungsformen sowie die danach erhältlichen Darreichungsformen
WO1987003805A1 (en) * 1985-12-19 1987-07-02 Capsoid Pharma Gmbh Process for producing shapes for administering individual doses and shapes thus produced
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
EP0596203B1 (de) * 1992-08-13 1999-11-17 BASF Aktiengesellschaft Wirkstoffe und wasserlösliche Polymeren enthaltende Zubereitungen in Form fester Teilchen
WO1995023591A1 (en) * 1994-03-03 1995-09-08 The Procter & Gamble Company Oral vehicle compositions
WO1996011674A1 (fr) * 1994-10-14 1996-04-25 Institut De Recherche Jouveinal Procede de preparation de formes pharmaceutiques a liberation controllee
FR2725624A1 (fr) * 1994-10-14 1996-04-19 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
WO1998010752A2 (de) * 1996-09-13 1998-03-19 Basf Aktiengesellschaft Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
WO1998010752A3 (de) * 1996-09-13 1998-06-18 Basf Ag Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
WO1998026865A1 (en) * 1996-12-17 1998-06-25 Chemcolloids Limited Encapsulation
AU727915B2 (en) * 1996-12-17 2001-01-04 Chemcolloids Limited Encapsulation
WO1999024020A1 (en) * 1997-11-12 1999-05-20 The Dow Chemical Company A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
WO1999034780A1 (de) * 1998-01-12 1999-07-15 Bühler AG Verfahren und vorrichtung zum verkapseln von wirkstoffen

Also Published As

Publication number Publication date
JPS499480A (US20090163788A1-20090625-C00002.png) 1974-01-28
FR2179044B1 (US20090163788A1-20090625-C00002.png) 1980-05-23
GB1388786A (en) 1975-03-26
JPS5116926B2 (US20090163788A1-20090625-C00002.png) 1976-05-28
DE2316242A1 (de) 1973-12-06
CA1041905A (en) 1978-11-07

Similar Documents

Publication Publication Date Title
JPS49133928A (US20090163788A1-20090625-C00002.png)
FR2179044B1 (US20090163788A1-20090625-C00002.png)
DK129371C (US20090163788A1-20090625-C00002.png)
JPS5239224B2 (US20090163788A1-20090625-C00002.png)
JPS517636B2 (US20090163788A1-20090625-C00002.png)
JPS4945618U (US20090163788A1-20090625-C00002.png)
JPS494520U (US20090163788A1-20090625-C00002.png)
FR2178430A5 (US20090163788A1-20090625-C00002.png)
JPS5555213Y2 (US20090163788A1-20090625-C00002.png)
JPS5123338B2 (US20090163788A1-20090625-C00002.png)
JPS5125814B2 (US20090163788A1-20090625-C00002.png)
JPS4885839A (US20090163788A1-20090625-C00002.png)
JPS4977712U (US20090163788A1-20090625-C00002.png)
CU33980A (US20090163788A1-20090625-C00002.png)
JPS4997051U (US20090163788A1-20090625-C00002.png)
JPS4999480U (US20090163788A1-20090625-C00002.png)
JPS49102721U (US20090163788A1-20090625-C00002.png)
JPS4893096A (US20090163788A1-20090625-C00002.png)
JPS4888404U (US20090163788A1-20090625-C00002.png)
JPS48105612U (US20090163788A1-20090625-C00002.png)
JPS4881861A (US20090163788A1-20090625-C00002.png)
JPS48100049U (US20090163788A1-20090625-C00002.png)
JPS4890737A (US20090163788A1-20090625-C00002.png)
JPS4990222U (US20090163788A1-20090625-C00002.png)
CH579538A5 (US20090163788A1-20090625-C00002.png)

Legal Events

Date Code Title Description
ST Notification of lapse